Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Above 50 Day Moving Average – What’s Next?

Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $10.22 and traded as high as $11.19. Ono Pharmaceutical shares last traded at $11.19, with a volume of 4,180 shares changing hands.

Ono Pharmaceutical Stock Performance

The company has a market capitalization of $5.25 billion, a P/E ratio of 10.75 and a beta of 0.73. The firm has a 50 day moving average price of $10.25 and a two-hundred day moving average price of $11.62. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.80 and a current ratio of 3.55.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its quarterly earnings data on Monday, February 3rd. The company reported $0.21 earnings per share for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.